BioCentury
ARTICLE | Company News

Dara BioSciences sales and marketing update

June 11, 2012 7:00 AM UTC

Dara launched Bionect 0.2% hyaluronic acid in the U.S. to treat skin irritation and burns associated with radiation therapy. Dara has exclusive, U.S. commercialization rights to Bionect for cancer an...